Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1982 Oct 1;156(4):1268–1273. doi: 10.1084/jem.156.4.1268

The acute-phase response in (NZB X NZW)F1 and MRL/l MICE

PMCID: PMC2186802  PMID: 7153712

Abstract

The acute-phase plasma protein response to disease activity in murine models of autoimmune lupus-like disease was investigated by measurement of the concentration of serum amyloid P component (SAP) in NZB X W and MRL/l mice. The levels of SAP, which is a major acute-phase protein in mice, did not rise at all in response to progression of disease in NZB X W mice between the ages of 1 and 9 mo. This resembles the behavior of acute-phase proteins such as C-reactive protein and serum amyloid A protein in human systemic lupus erythematosus, and just as in human lupus, where the occurrence of intercurrent microbial infection can stimulate an acute-phase response, so injection of bacterial lipopolysaccharide or casein into the NZB X W mice stimulated "normal" acute-phase SAP production. In marked contrast, MRL/l mice developed greatly increased levels of SAP, which correlated closely with progression of their pathology as they aged. The disease profile of the MRL/l strain includes rheumatoid factors and spontaneous polyarthritis and their SAP response resembles the behavior of acute phase proteins in human rheumatoid arthritis. Different patterns of acute-phase response in different autoimmune disorders may thus be a reflection of the genetic predisposition to particular diseases and/or contribute to their pathogenesis. The existence of animal counterparts for the various clinical patterns of human acute-phase protein production will assist in experimental investigation of the underlying mechanisms and of the biological role of the acute-phase response.

Full Text

The Full Text of this article is available as a PDF (341.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baltz M. L., de Beer F. C., Feinstein A., Munn E. A., Milstein C. P., Fletcher T. C., March J. F., Taylor J., Bruton C., Clamp J. R. Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci. 1982;389:49–75. doi: 10.1111/j.1749-6632.1982.tb22125.x. [DOI] [PubMed] [Google Scholar]
  3. De Beer F. C., Mallya R. K., Fagan E. A., Lanham J. G., Hughes G. R., Pepys M. B. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet. 1982 Jul 31;2(8292):231–234. doi: 10.1016/s0140-6736(82)90321-x. [DOI] [PubMed] [Google Scholar]
  4. HOKAMA Y., COLEMAN M. K., RILEY R. F. Cx-Reactive protein response in rabbits during immunization with foreign proteins. J Immunol. 1960 Jul;85:72–77. [PubMed] [Google Scholar]
  5. Hang L., Theofilopoulos A. N., Dixon F. J. A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med. 1982 Jun 1;155(6):1690–1701. doi: 10.1084/jem.155.6.1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  7. Hunt J. S., Kennedy M. P., Barber K. E., McGiven A. R. A microplate adaptation of the solid-phase C1q immune complex assay. J Immunol Methods. 1980;33(3):267–275. doi: 10.1016/0022-1759(80)90214-8. [DOI] [PubMed] [Google Scholar]
  8. Izui S., Kelley V. E., McConahey P. J., Dixon F. J. Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus. J Exp Med. 1980 Dec 1;152(6):1645–1658. doi: 10.1084/jem.152.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KUSHNER I., KAPLAN M. H. STUDIES OF ACUTE PHASE PROTEIN. III. ELICITATION OF CX-REACTIVE PROTEIN IN RELATION TO IMMUNE ELIMINATION OF ANTIGEN AND APPEARANCE OF CIRCULATING ANTIGEN-ANTIBODY COMPLEXES. J Immunol. 1964 Jan;92:55–60. [PubMed] [Google Scholar]
  10. Kelley V. E., Winkelstein A., Izui S. Effect of prostaglandin E on immune complex nephritis in NZB/W mice. Lab Invest. 1979 Dec;41(6):531–537. [PubMed] [Google Scholar]
  11. Klotz J. L., Minami R. M., Teplitz R. L. An enzyme-linked immunosorbent assay for antibodies to native and denatured DNA. J Immunol Methods. 1979;29(2):155–165. doi: 10.1016/0022-1759(79)90065-6. [DOI] [PubMed] [Google Scholar]
  12. Mallya R. K., Vergani D., Tee D. E., Bevis L., de Beer F. C., Berry H., Hamilton E. D., Mace B. E., Pepys M. B. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. Clin Exp Immunol. 1982 Jun;48(3):747–753. [PMC free article] [PubMed] [Google Scholar]
  13. Mallya R. K., de Beer F. C., Berry H., Hamilton E. D., Mace B. E., Pepys M. B. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol. 1982 Mar-Apr;9(2):224–228. [PubMed] [Google Scholar]
  14. Pepys M. B., Baltz M., Gomer K., Davies A. J., Doenhoff M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature. 1979 Mar 15;278(5701):259–261. doi: 10.1038/278259a0. [DOI] [PubMed] [Google Scholar]
  15. Pepys M. B. Isolation of serum amyloid P-component (protein SAP) in the mouse. Immunology. 1979 Jul;37(3):637–641. [PMC free article] [PubMed] [Google Scholar]
  16. Pepys M. B., Lanham J. G., De Beer F. C. C-reactive protein in SLE. Clin Rheum Dis. 1982 Apr;8(1):91–103. [PubMed] [Google Scholar]
  17. Ulevitch R. J., Johnston A. R., Weinstein D. B. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest. 1979 Nov;64(5):1516–1524. doi: 10.1172/JCI109610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Whicher J. T., Martin M. F., Dieppe P. A. Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis. Lancet. 1980 Nov 29;2(8205):1187–1188. doi: 10.1016/s0140-6736(80)92614-8. [DOI] [PubMed] [Google Scholar]
  19. Zurier R. B., Damjanov I., Sayadoff D. M., Rothfield N. F. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum. 1977 Nov-Dec;20(8):1449–1456. doi: 10.1002/art.1780200802. [DOI] [PubMed] [Google Scholar]
  20. de Beer F. C., Baltz M. L., Holford S., Feinstein A., Pepys M. B. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med. 1981 Oct 1;154(4):1134–1139. doi: 10.1084/jem.154.4.1134. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES